In the not too distant past, it would have seemed unbelievable that, as the significance of the new infection became apparent, scientists in China would be able to sequence the complete viral genome within hours and make this freely available online to researchers across the globe; this enables fresh, rapid detection systems for both the disease and antiviral antibodies to be developed in short order. Simultaneously, laboratories flipped their attention to the challenge of developing vaccines that, whilst they may not be available to confine the initial outbreaks, may help minimise the effects of the subsequent rounds of infection that will appear as present societal constraints are relaxed and could protect against future outbreaks of the SARS\CoV\2 virus infection. Additional laboratories are concentrating on determining possible therapeutics to lessen the effect of infection. Of course, in the long run the R&D must be put on real produce, which is where the response, inevitably, may slow down. The practicality of the various novel vaccine platforms has to be validated through safety and efficacy testing. For vaccines, this normally can take many years, but pharmaceutical licencing authorities are seeking to fast track their approval processes, whilst minimising the risk of unintended consequences. At the ultimate end of the chain sits produce. Are there appropriate facilities available and so are there plenty of technical workers been trained in Pharmaceutical Great manufacturing practice to create sufficient levels of many book vaccines to facilitate early protection and efficacy research and, eventually, deliver the mandatory levels of item to the proper timescale and quality? At least with this last respect Big Pharma can be showing its determination to contribute. Whenever we emerge out of this problems right now there will, justifiably, be compliment and thanks for individuals who contributed and sacrificed a lot for his or her fellow residents. Politicians will, no doubt, be self congratulatory but will they look at their prior actions, or inactions, that may have made the battle so much more difficult? China has taken bold societal actions that seem to have been effective. South Korea is one country which seems to have been well prepared and effective in its actions especially in respect of compliance with WHO pandemic advice, undoubtedly because of its previous experience with the earlier SARS epidemic. Elsewhere, governmental responses have varied with some seemingly avoiding compliance with WHO guidelines on pandemics and others following this advice. This uneven approach will hinder our full understanding of the pandemic and the benefit, or otherwise, of the various responses. The advice of scientific experts has, perhaps belatedly, been taken on board in many countries, as witness the new phenomenon of em social distancing /em . Engineers and Scientists, functioning hard to supply accurate and proper info in scientific sites and publications, have got long advised government authorities of the necessity to insure against potential disasters by paying the required insurance policy monthly premiums. Not only will this consist of fundamental study on infectious illnesses, public health features, raising public recognition, stockpiling of professional tools and protecting crisis and clothes production ability, however the broader environmental conditions that threaten populations globally also. We are able to but wish that today’s problems makes our market leaders extend their politics look at to broader horizons. Executive Editor Peter Hambleton. been significant also. In the not really too distant history, it would possess seemed incredible that, as the importance of the new contamination became apparent, scientists in China would be able to sequence the complete viral genome within hours and make 2-Deoxy-D-glucose this freely available online to researchers across the globe; this enables new, rapid detection systems for both the virus and antiviral antibodies to be developed in short order. Simultaneously, laboratories switched their attention to the challenge of developing vaccines that, whilst they may not be available to confine the initial outbreaks, may help minimise the effects of the subsequent rounds of contamination that will appear as present societal constraints are relaxed and could protect 2-Deoxy-D-glucose against future outbreaks of the SARS\CoV\2 virus contamination. Other laboratories are focusing on identifying possible therapeutics to reduce the impact of contamination. Of course, in the long run the R&D must be applied to real manufacture, which is certainly where in fact the response, undoubtedly, may decelerate. The practicality of the many novel vaccine systems must be validated through protection and efficacy tests. For vaccines, this normally may take a long time, but pharmaceutical licencing specialists would like to fast monitor their approval procedures, whilst minimising the chance of unintended implications. By the end of this string sits manufacture. Is there ideal facilities available and so are there more than enough technical workers been trained in Pharmaceutical Great manufacturing practice to create sufficient levels of many book vaccines to facilitate early basic safety and efficacy research and, ultimately, deliver the mandatory quantities GFAP of item to the proper quality and timescale? At least within this last respect Big Pharma is certainly showing its determination to contribute. Whenever we emerge out of this turmoil there will, justifiably, end up being praise and thanks a lot for individuals who added and sacrificed a lot because of their fellow people. Politicians will, without doubt, end up being personal congratulatory but will they take a look at their prior actions, or inactions, that may have made the battle so much more hard? China has taken bold societal actions that seem to have been effective. South Korea is usually one country which seems to have been well prepared and effective in its actions 2-Deoxy-D-glucose especially in respect of compliance with WHO pandemic guidance, undoubtedly because of its previous experience with the earlier SARS epidemic. Elsewhere, governmental responses have varied with some seemingly avoiding compliance with WHO guidelines on pandemics as well as others following this guidance. This uneven approach will hinder our full understanding of the pandemic and the benefit, or otherwise, of the various responses. The guidance of scientific experts has, perhaps belatedly, been taken on board in many countries, as witness the new phenomenon of em interpersonal distancing /em . Scientists and engineers, working hard to provide accurate and proper information in scientific journals and sites, have 2-Deoxy-D-glucose long advised governments of the need to insure against future disasters by paying the necessary insurance policy premiums. Not only does this include fundamental research on infectious diseases, public health capabilities, raising public consciousness, stockpiling of specialist equipment and protective clothing and emergency manufacturing capability, but also the broader environmental issues that threaten populations globally. We can but hope that the present crisis makes our leaders extend their political view to broader horizons. Professional Editor Peter Hambleton.